BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases
Westport, CT, Feb. 06, 2024 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ:BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced that physicians have completed over 100 cases with the Near Field Tracking (“NFT”) algorithm, an innovative and proprietary feature recently launched on the Company’s PURE EP™ Platform.
Related news for (BSGM)
- Breaking News: MoBot’s Latest Update as of 09/11/25 02:00 PM
- MoBot’s Stock Market Highlights – 09/11/25 11:00 AM
- BioSig Technologies Inc. Announces Pricing of $15 Million Public Offering
- 24/7 Market News Snapshot 14 August, 2025 – BioSig Technologies, Inc. Common Stock (NASDAQ:BSGM)
- Today’s Top Performers: MoBot’s Market Review 07/21/25 05:00 PM